{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:31:24Z","timestamp":1792672284152,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T00:00:00Z","timestamp":1534464000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13321-018-0291-x","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T07:21:14Z","timestamp":1534490474000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Predictive classification models and targets identification for betulin derivatives as Leishmania donovani inhibitors"],"prefix":"10.1186","volume":"10","author":[{"given":"Yuezhou","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Xhaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3591-5676","authenticated-orcid":false,"given":"Leo","family":"Ghemtio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,17]]},"reference":[{"issue":"5","key":"291_CR1","doi-asserted-by":"publisher","first-page":"E35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J et al (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE 7(5):E35671","journal-title":"PLoS ONE"},{"issue":"4","key":"291_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1128\/CMR.00080-14","volume":"28","author":"ZR Lun","year":"2015","unstructured":"Lun ZR, Wu MS, Chen YF, Wang JY, Zhou XN, Liao LF et al (2015) Visceral leishmaniasis in China: an endemic disease under control. Clin Microbiol Rev 28(4):987\u20131004","journal-title":"Clin Microbiol Rev"},{"key":"291_CR3","doi-asserted-by":"publisher","first-page":"140036","DOI":"10.1038\/sdata.2014.36","volume":"1","author":"DM Pigott","year":"2014","unstructured":"Pigott DM, Golding N, Messina JP, Battle KE, Duda KA, Balard Y et al (2014) Global database of leishmaniasis occurrence locations, 1960\u20132012. Sci Data 1:140036","journal-title":"Sci Data"},{"issue":"2","key":"291_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4103\/0974-777X.62879","volume":"2","author":"E Palumbo","year":"2010","unstructured":"Palumbo E (2010) Treatment strategies for mucocutaneous leishmaniasis. J Glob Infect Dis 2(2):147\u2013150","journal-title":"J Glob Infect Dis"},{"issue":"11","key":"291_CR5","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nrmicro1748","volume":"5","author":"F Chappuis","year":"2007","unstructured":"Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Rw Peeling et al (2007) Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 5(11):873\u2013882","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"291_CR6","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.bmc.2010.01.003","volume":"18","author":"S Alakurtti","year":"2010","unstructured":"Alakurtti S, Heiska T, Kiriazis A, Sacerdoti-Sierra N, Jaffe CL, Yli-Kauhaluoma J (2010) Synthesis and anti-leishmanial activity of heterocyclic betulin derivatives. Bioorg Med Chem 18(4):1573\u20131582","journal-title":"Bioorg Med Chem"},{"issue":"6","key":"291_CR7","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1039\/b100455g","volume":"18","author":"MJ Chan-Bacab","year":"2001","unstructured":"Chan-Bacab MJ, Pe\u00f1a-Rodr\u00edguez LM (2001) Plant natural products with leishmanicidal activity. Nat Prod Rep 18(6):674\u2013688","journal-title":"Nat Prod Rep"},{"issue":"5","key":"291_CR8","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1021\/jm950670t","volume":"39","author":"M Evers","year":"1996","unstructured":"Evers M, Poujade C, Soler F, Ribeill Y, James C, Lelievre Y et al (1996) Betulinic acid derivatives: a new class of human immunodeficiency virus type 1 specific inhibitors with a new mode of action. J Med Chem 39(5):1056\u20131068","journal-title":"J Med Chem"},{"issue":"5","key":"291_CR9","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0367-326X(03)00123-0","volume":"74","author":"NI Pavlova","year":"2003","unstructured":"Pavlova NI, Savinova OV, Nikolaeva SN, Boreko EI, Flekhter OB (2003) Antiviral activity of betulin, betulinic and betulonic acids against some enveloped and non-enveloped viruses. Fitoterapia 74(5):489\u2013492","journal-title":"Fitoterapia"},{"issue":"11","key":"291_CR10","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1021\/np9003245","volume":"72","author":"L Pohjala","year":"2009","unstructured":"Pohjala L, Alakurtti S, Ahola T, Yli-Kauhaluoma J, Tammela P (2009) Betulin-derived compounds as inhibitors of alphavirus replication. J Nat Prod 72(11):1917\u20131926","journal-title":"J Nat Prod"},{"issue":"16","key":"291_CR11","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1016\/j.bmcl.2015.05.099","volume":"25","author":"RJ Visalli","year":"2015","unstructured":"Visalli RJ, Ziobrowski H, Badri KR, He JJ, Zhang XG, Arumugam SR et al (2015) Ionic derivatives of betulinic acid exhibit antiviral activity against herpes simplex virus type-2 (hsv-2), but not hiv-1 reverse transcriptase. Bioorg Med Chem Lett 25(16):3168\u20133171","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"291_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.molmed.2004.11.001","volume":"11","author":"C Aiken","year":"2005","unstructured":"Aiken C, Chen Ch (2005) Betulinic acid derivatives as hiv-1 antivirals. Trends Mol Med 11(1):31\u201336","journal-title":"Trends Mol Med"},{"issue":"9","key":"291_CR13","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1023\/A:1021844705853","volume":"36","author":"OB Flekhter","year":"2002","unstructured":"Flekhter OB, Nigmatullina LR, Baltina LA, Karachurina LT, Galin FZ, Zarudii FS et al (2002) Synthesis of betulinic acid from betulin extract and study of the antiviral and antiulcer activity of some related terpenoids. Pharm Chem J 36(9):484\u2013487","journal-title":"Pharm Chem J"},{"issue":"2","key":"291_CR14","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.intimp.2014.09.021","volume":"23","author":"JFO Costa","year":"2014","unstructured":"Costa JFO, Barbosa JM, Maia GLD, Guimaraes ET, Meira CS, Ribeiro-Dos-Santos R et al (2014) Potent anti-inflammatory activity of betulinic acid treatment in a model of lethal endotoxemia. Int Immunopharmacol 23(2):469\u2013474","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"291_CR15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1021\/acs.jnatprod.5b00709","volume":"79","author":"M Laavola","year":"2016","unstructured":"Laavola M, Haavikko R, Hamalainen M, Leppanen T, Nieminen R, Alakurtti S et al (2016) Betulin derivatives effectively suppress inflammation in vitro and in vivo. J Nat Prod 79(2):274\u2013280","journal-title":"J Nat Prod"},{"issue":"1","key":"291_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00436-009-1394-0","volume":"105","author":"MS De Sa","year":"2009","unstructured":"De Sa MS, Costa JFO, Krettli AU, Zalis MG, Maia GLD, Sette IMF et al (2009) Antimalarial activity of betulinic acid and derivatives in vitro against plasmodium falciparum and in vivo in p-berghei-infected mice. Parasitol Res 105(1):275\u2013279","journal-title":"Parasitol Res"},{"issue":"1","key":"291_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/tmi.12395","volume":"20","author":"GNS Silva","year":"2015","unstructured":"Silva GNS, Schuck DC, Cruz LN, Moraes MS, Nakabashi M, Gosmann G et al (2015) Investigation of antimalarial activity, cytotoxicity and action mechanism of piperazine derivatives of betulinic acid. Trop Med Int Health 20(1):29\u201339","journal-title":"Trop Med Int Health"},{"key":"291_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/584189","author":"SK Kr\u00f3l","year":"2015","unstructured":"Kr\u00f3l SK, Kie\u0142bus M, Rivero-M\u00fcller A, Stepulak A (2015) Comprehensive review on betulin as a potent anticancer agent. BioMed Res Int. \n                    https:\/\/doi.org\/10.1155\/2015\/584189","journal-title":"BioMed Res Int"},{"key":"291_CR19","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.biopha.2017.08.104","volume":"95","author":"L Szoka","year":"2017","unstructured":"Szoka L, Karna E, Hlebowicz-Sarat K, Karaszewski J, Boryczka S, Palka JA (2017) Acetylenic derivative of betulin induces apoptosis in endometrial adenocarcinoma cell line. Biomed Pharmacother 95:429\u2013436","journal-title":"Biomed Pharmacother"},{"issue":"14","key":"291_CR20","doi-asserted-by":"publisher","first-page":"6353","DOI":"10.1021\/acs.jmedchem.7b00679","volume":"60","author":"Y Ye","year":"2017","unstructured":"Ye Y, Zhang T, Yuan H, Li D, Lou H, Fan P (2017) Mitochondria-targeted lupane triterpenoid derivatives and their selective apoptosis-inducing anticancer mechanisms. J Med Chem 60(14):6353\u20136363","journal-title":"J Med Chem"},{"issue":"21","key":"291_CR21","first-page":"4956","volume":"57","author":"S Fulda","year":"1997","unstructured":"Fulda S, Friesen C, Los M, Scaffidi C, Mier W, Benedict M et al (1997) Betulinic acid triggers cd95 (apo-1\/fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res 57(21):4956\u20134964","journal-title":"Cancer Res"},{"issue":"4","key":"291_CR22","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1128\/AAC.45.4.1225-1230.2001","volume":"45","author":"T Kanamoto","year":"2001","unstructured":"Kanamoto T, Kashiwada Y, Kanbara K, Gotoh K, Yoshimori M, Goto T et al (2001) Anti-human immunodeficiency virus activity of yk-fh312 (a betulinic acid derivative), a novel compound blocking viral maturation. Antimicrob Agents Chemother 45(4):1225\u20131230","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"291_CR23","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/nm1095-1046","volume":"1","author":"E Pisha","year":"1995","unstructured":"Pisha E, Chai H, Is Lee, Te Chagwedera, Nr Farnsworth, Ga Cordell et al (1995) Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat Med 1(10):1046\u20131051","journal-title":"Nat Med"},{"issue":"2","key":"291_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/(SICI)1099-1573(199903)13:2<115::AID-PTR404>3.0.CO;2-1","volume":"13","author":"JC Steele","year":"1999","unstructured":"Steele JC, Warhurst DC, Kirby GC, Simmonds MS (1999) In vitro and in vivo evaluation of betulinic acid as an antimalarial. Phytother Res 13(2):115\u2013119","journal-title":"Phytother Res"},{"issue":"1","key":"291_CR25","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1021\/jm900872z","volume":"53","author":"C Genet","year":"2010","unstructured":"Genet C, Strehle A, Schmidt C, Boudjelal G, Lobstein A, Schoonjans K et al (2010) Structure\u2013activity relationship study of betulinic acid, a novel and selective tgr5 agonist, and its synthetic derivatives: potential impact in diabetes. J Med Chem 53(1):178\u2013190","journal-title":"J Med Chem"},{"issue":"3","key":"291_CR26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2174\/187152006776930846","volume":"6","author":"R Mukherjee","year":"2006","unstructured":"Mukherjee R, Kumar V, Srivastava SK, Agarwal SK, Burman AC (2006) Betulinic acid derivatives as anticancer agents: structure activity relationship. Anticancer Agents Med Chem 6(3):271\u2013279","journal-title":"Anticancer Agents Med Chem"},{"issue":"3","key":"291_CR27","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/bcpt.12221","volume":"115","author":"MTDS Souza","year":"2014","unstructured":"Souza MTDS, Almeida JRGDS, Araujo AADS, Duarte MC, Gelain DP, Moreira JCF et al (2014) Structure\u2013activity relationship of terpenes with anti-inflammatory profile\u2014a systematic review. Basic Clin Pharmacol Toxicol 115(3):244\u2013256","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"291_CR28","doi-asserted-by":"publisher","first-page":"e89939","DOI":"10.1371\/journal.pone.0089939","volume":"9","author":"MC Sousa","year":"2014","unstructured":"Sousa MC, Varandas R, Santos RC, Santos-Rosa M, Alves V, Salvador JA (2014) Antileishmanial activity of semisynthetic lupane triterpenoids betulin and betulinic acid derivatives: synergistic effects with miltefosine. PLoS ONE 9(3):e89939","journal-title":"PLoS ONE"},{"issue":"1","key":"291_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejps.2006.04.006","volume":"29","author":"S Alakurtti","year":"2006","unstructured":"Alakurtti S, Makela T, Koskimies S, Yli-Kauhaluoma J (2006) Pharmacological properties of the ubiquitous natural product betulin. Eur J Pharm Sci 29(1):1\u201313","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"291_CR30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/ja.2010.2","volume":"63","author":"S Alakurtti","year":"2010","unstructured":"Alakurtti S, Bergstrom P, Sacerdoti-Sierra N, Jaffe CL, Yli-Kauhaluoma J (2010) Anti-leishmanial activity of betulin derivatives. J Antibiot (Tokyo) 63(3):123\u2013126","journal-title":"J Antibiot (Tokyo)"},{"issue":"4","key":"291_CR31","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1039\/C3MD00282A","volume":"5","author":"R Haavikko","year":"2014","unstructured":"Haavikko R, Nasereddin A, Sacerdoti-Sierra N, Kopelyanskiy D, Alakurtti S, Tikka M et al (2014) Heterocycle-fused lupane triterpenoids inhibit Leishmania donovani amastigotes. Medchemcomm 5(4):445\u2013451","journal-title":"Medchemcomm"},{"issue":"12","key":"291_CR32","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1021\/jm4004285","volume":"57","author":"A Cherkasov","year":"2014","unstructured":"Cherkasov A, Muratov En, Fourches D, Varnek A, Baskin II, Cronin M et al (2014) Qsar modeling: where have you been? where are you going to? J Med Chem 57(12):4977\u20135010","journal-title":"J Med Chem"},{"issue":"1","key":"291_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1089\/adt.2014.625","volume":"13","author":"S Nybond","year":"2015","unstructured":"Nybond S, Ghemtio L, Nawrot DA, Karp M, Xhaard H, Tammela P (2015) Integrated in vitro\u2013in silico screening strategy for the discovery of antibacterial compounds. Assay Drug Dev Technol 13(1):25\u201333","journal-title":"Assay Drug Dev Technol"},{"issue":"1","key":"291_CR34","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1124\/pr.112.007336","volume":"66","author":"G Sliwoski","year":"2014","unstructured":"Sliwoski G, Kothiwale S, Meiler J, Lowe EW (2014) Computational methods in drug discovery. Pharmacol Rev 66(1):334\u2013395","journal-title":"Pharmacol Rev"},{"issue":"10","key":"291_CR35","doi-asserted-by":"publisher","first-page":"e0141943","DOI":"10.1371\/journal.pone.0141943","volume":"10","author":"EM Amo del","year":"2015","unstructured":"del Amo EM, Ghemtio L, Xhaard H, Yliperttula M, Urtti A, Kidron H (2015) Correction: applying linear and non-linear methods for parallel prediction of volume of distribution and fraction of unbound drug. PLoS ONE 10(10):e0141943","journal-title":"PLoS ONE"},{"issue":"5","key":"291_CR36","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1021\/ci900356m","volume":"50","author":"L Ghemtio","year":"2010","unstructured":"Ghemtio L, Devignes MD, Sma\u00efl-Tabbone M, Souchet M, Leroux V, Maigret B (2010) Comparison of three preprocessing filters efficiency in virtual screening: identification of new putative LXR\u03b2 regulators as a test case. J Chem Inf Model 50(5):701\u2013715","journal-title":"J Chem Inf Model"},{"issue":"8","key":"291_CR37","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1007\/s00894-013-1821-0","volume":"19","author":"L Ghemtio","year":"2013","unstructured":"Ghemtio L, Muzet N (2013) Retrospective molecular docking study of Wy-25105 ligand to beta-secretase and bias of the three-dimensional structure flexibility. J Mol Model 19(8):2971\u20132979","journal-title":"J Mol Model"},{"issue":"4","key":"291_CR38","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1021\/ci400577a","volume":"54","author":"L Ghemtio","year":"2014","unstructured":"Ghemtio L, Soikkeli A, Yliperttula M, Hirvonen J, Finel M, Xhaard H (2014) Svm classification and Comsia modeling of Ugt1a6 interacting molecules. J Chem Inf Model 54(4):1011\u20131026","journal-title":"J Chem Inf Model"},{"issue":"8","key":"291_CR39","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s00044-010-9467-2","volume":"20","author":"P Lan","year":"2011","unstructured":"Lan P, Chen WN, Sun PH, Chen WM (2011) 3D-QSAR studies on betulinic acid and betulin derivatives as anti-HIV-1 agents using CoMFA and CoMSIA. Med Chem Res 20(8):1247\u20131259","journal-title":"Med Chem Res"},{"issue":"9","key":"291_CR40","doi-asserted-by":"publisher","first-page":"10228","DOI":"10.3390\/molecules180910228","volume":"18","author":"W Ding","year":"2013","unstructured":"Ding W, Sun M, Luo S, Xu T, Cao Y, Yan X, Wang Y (2013) A 3D QSAR study of betulinic acid derivatives as anti-tumor agents using topomer CoMFA: model building studies and experimental verification. Molecules 18(9):10228\u201310241","journal-title":"Molecules"},{"issue":"7","key":"291_CR41","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s00894-010-0870-x","volume":"17","author":"P Lan","year":"2011","unstructured":"Lan P, Chen WN, Huang ZJ, Sun PH, Chen WM (2011) Understanding the structure-activity relationship of betulinic acid derivatives as anti-HIV-1 agents by using 3D-QSAR and docking. J Mol Model 17(7):1643\u20131659","journal-title":"J Mol Model"},{"issue":"2","key":"291_CR42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/10575630290020000","volume":"16","author":"JK Rugutt","year":"2002","unstructured":"Rugutt JK, Rugutt KJ (2002) Relationships between molecular properties and antimycobacterial activities of steroids. Nat Prod Lett 16(2):107\u2013113","journal-title":"Nat Prod Lett"},{"issue":"8","key":"291_CR43","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1039\/c2ra01345b","volume":"2","author":"Y Hu","year":"2012","unstructured":"Hu Y, Bajorath J (2012) Many structurally related drugs bind different targets whereas distinct drugs display significant target overlap. RSC Adv 2(8):3481\u20133489","journal-title":"RSC Adv"},{"issue":"19","key":"291_CR44","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1021\/jm020155c","volume":"45","author":"YC Martin","year":"2002","unstructured":"Martin YC, Kofron JL, Traphagen LM (2002) Do structurally similar molecules have similar biological activity? J Med Chem 45(19):4350\u20134358","journal-title":"J Med Chem"},{"issue":"23","key":"291_CR45","doi-asserted-by":"publisher","first-page":"6716","DOI":"10.1021\/jm060167o","volume":"49","author":"J Bostrom","year":"2006","unstructured":"Bostrom J, Hogner A, Schmitt S (2006) Do structurally similar ligands bind in a similar fashion? J Med Chem 49(23):6716\u20136725","journal-title":"J Med Chem"},{"issue":"4","key":"291_CR46","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1021\/ci300083r","volume":"52","author":"J Meslamani","year":"2012","unstructured":"Meslamani J, Li J, Sutter J, Stevens A, Bertrand HO, Rognan D (2012) Protein\u2013ligand-based pharmacophores: generation and utility assessment in computational ligand profiling. J Chem Inf Model 52(4):943\u2013955","journal-title":"J Chem Inf Model"},{"issue":"2","key":"291_CR47","first-page":"123","volume":"24","author":"L Breiman","year":"1996","unstructured":"Breiman L (1996) Bagging predictors. Mach Learn 24(2):123\u2013140","journal-title":"Mach Learn"},{"issue":"6","key":"291_CR48","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1021\/ci9800211","volume":"38","author":"P Willett","year":"1998","unstructured":"Willett P, Barnard JM, Downs GM (1998) Chemical similarity searching. J Chem Inf Comput Sci 38(6):983\u2013996","journal-title":"J Chem Inf Comput Sci"},{"key":"291_CR49","volume-title":"Classification and regression trees","author":"L Breiman","year":"1984","unstructured":"Breiman L, Friedman J, Stone CJ, Olshen RA (1984) Classification and regression trees. Taylor & Francis, Milton Park"},{"key":"291_CR50","volume-title":"Similarity, dissimilarity and distance, measures of encyclopedia of statistical sciences","author":"JC Gower","year":"2004","unstructured":"Gower JC (2004) Similarity, dissimilarity and distance, measures of encyclopedia of statistical sciences. Wiley, Hoboken"},{"issue":"2","key":"291_CR51","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1023\/A:1010920819831","volume":"45","author":"DJ Hand","year":"2001","unstructured":"Hand DJ, Till RJ (2001) A simple generalisation of the area under the roc curve for multiple class classification problems. Mach Learn 45(2):171\u2013186","journal-title":"Mach Learn"},{"issue":"4","key":"291_CR52","doi-asserted-by":"publisher","first-page":"E203","DOI":"10.1016\/j.ddtec.2010.11.006","volume":"7","author":"D Schuster","year":"2010","unstructured":"Schuster D (2010) 3d pharmacophores as tools for activity profiling. Drug Discov Today Technol 7(4):E203\u2013E270","journal-title":"Drug Discov Today Technol"},{"issue":"9","key":"291_CR53","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1093\/bioinformatics\/btr120","volume":"27","author":"J Meslamani","year":"2011","unstructured":"Meslamani J, Rognan D, Kellenberger E (2011) Sc-Pdb: a database for identifying variations and multiplicity of \u2018druggable\u2019 binding sites in proteins. Bioinformatics 27(9):1324\u20131326","journal-title":"Bioinformatics"},{"issue":"12","key":"291_CR54","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s10822-006-9066-y","volume":"20","author":"TM Steindl","year":"2006","unstructured":"Steindl TM, Schuster D, Wolber G, Laggner C, Langer T (2006) High-throughput structure-based pharmacophore modelling as a basis for successful parallel virtual screening. J Comput Aided Mol Des 20(12):703\u2013715","journal-title":"J Comput Aided Mol Des"},{"issue":"D1","key":"291_CR55","doi-asserted-by":"publisher","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","volume":"45","author":"A Gaulton","year":"2017","unstructured":"Gaulton A, Hersey A, Nowotka M, Bento AP, Chambers J, Mendez D et al (2017) The chembl database in 2017. Nucl Acids Res 45(D1):D945\u2013D954","journal-title":"Nucl Acids Res"},{"issue":"D1","key":"291_CR56","doi-asserted-by":"publisher","first-page":"D488","DOI":"10.1093\/nar\/gkv1024","volume":"44","author":"M Kutmon","year":"2016","unstructured":"Kutmon M, Riutta A, Nunes N, Hanspers K, El Willighagen, Bohler A et al (2016) Wikipathways: capturing the full diversity of pathway knowledge. Nucl Acids Res 44(D1):D488\u2013D494","journal-title":"Nucl Acids Res"},{"key":"291_CR57","unstructured":"KNIME. \n                    http:\/\/www.knime.com\n                    \n                  . Accessed 6 Aug 2018"},{"issue":"3","key":"291_CR58","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/bioinformatics\/btq675","volume":"27","author":"ME Smoot","year":"2010","unstructured":"Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T (2010) Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27(3):431\u2013432","journal-title":"Bioinformatics"},{"issue":"11","key":"291_CR59","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/S0968-0004(98)01298-5","volume":"23","author":"SF Altschul","year":"1998","unstructured":"Altschul SF, Koonin EV (1998) Iterated profile searches with psi-blast\u2014a tool for discovery in protein databases. Trends Biochem Sci 23(11):444\u2013447","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"291_CR60","first-page":"153","volume":"22","author":"G Pearson","year":"2001","unstructured":"Pearson G, Robinson F, Beers Gibson T, Be Xu, Karandikar M, Berman K et al (2001) Mitogen-activated protein (map) kinase pathways: regulation and physiological functions. Endocr Rev 22(2):153\u2013183","journal-title":"Endocr Rev"},{"issue":"1","key":"291_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12639-010-0006-3","volume":"34","author":"B Chawla","year":"2010","unstructured":"Chawla B, Madhubala R (2010) Drug targets in Leishmania. J Parasit Dis Off Organ Indian Soc Parasitol 34(1):1\u201313","journal-title":"J Parasit Dis Off Organ Indian Soc Parasitol"},{"issue":"49","key":"291_CR62","doi-asserted-by":"publisher","first-page":"37964","DOI":"10.1074\/jbc.M110.155317","volume":"285","author":"R Pallavi","year":"2010","unstructured":"Pallavi R, Roy N, Rk Nageshan, Talukdar P, Sr Pavithra, Reddy R et al (2010) Heat shock protein 90 as a drug target against protozoan infections: biochemical characterization of Hsp90 from plasmodium falciparum and trypanosoma evansi and evaluation of its inhibitor as a candidate drug. J Biol Chem 285(49):37964\u201337975","journal-title":"J Biol Chem"},{"issue":"10","key":"291_CR63","doi-asserted-by":"publisher","first-page":"e2492","DOI":"10.1371\/journal.pntd.0002492","volume":"7","author":"JC Pizarro","year":"2013","unstructured":"Pizarro JC, Hills T, Senisterra G, Wernimont AK, Mackenzie C, Norcross NR et al (2013) Exploring the Trypanosoma brucei Hsp83 potential as a target for structure guided drug design. Plos Negl Trop Dis 7(10):e2492","journal-title":"Plos Negl Trop Dis"},{"issue":"8","key":"291_CR64","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrd4626","volume":"14","author":"L Lin","year":"2015","unstructured":"Lin L, Yee SW, Kim RB, Giacomini KM (2015) SLC transporters as therapeutic targets: emerging opportunities. Nat Rev Drug Discov 14(8):543\u2013560","journal-title":"Nat Rev Drug Discov"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-018-0291-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13321-018-0291-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-018-0291-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T19:04:28Z","timestamp":1565982268000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/s13321-018-0291-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,17]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["291"],"URL":"https:\/\/doi.org\/10.1186\/s13321-018-0291-x","relation":{},"ISSN":["1758-2946"],"issn-type":[{"value":"1758-2946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,17]]},"assertion":[{"value":"1 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"40"}}